TSW
PRTA icon

Thompson Siegel & Walmsley’s Prothena Corp PRTA Stock Holding History

Thompson Siegel & Walmsley’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-21
Closed -$1K – 901
2016
Q3 		$1K Hold
21
– – ﹤0.01% 714
2016
Q2 		$1K Hold
21
– – ﹤0.01% 757
2016
Q1 		$1K Buy
+21
New +$822 ﹤0.01% 683

Other funds holding PRTA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Thompson Siegel & Walmsley's PRTA Position: Q4 2016 in Review

Thompson Siegel & Walmsley sold out of Prothena Corp (PRTA) in Q4 2016, closing a stake of 21 shares — an estimated $1K sold.

Thompson Siegel & Walmsley first reported a position in PRTA in Q1 2016 and held it in 3 quarters. The position peaked at $1K in Q3 2016. 145 funds tracked by Wall St. Rank hold PRTA as of Q4 2016.

  • Thompson Siegel & Walmsley reported no remaining Prothena Corp position as of Q4 2016 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 21 Prothena Corp shares in Q4 2016, an estimated $1K.
  • Thompson Siegel & Walmsley first reported a position in Prothena Corp in Q1 2016 and held it in 3 quarters.
  • Thompson Siegel & Walmsley's Prothena Corp position peaked at $1K in Q3 2016.
  • 145 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2016.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2016, filed 13 Feb 2017.